GB201011819D0 - Neurodegenerative disorders - Google Patents
Neurodegenerative disordersInfo
- Publication number
- GB201011819D0 GB201011819D0 GBGB1011819.8A GB201011819A GB201011819D0 GB 201011819 D0 GB201011819 D0 GB 201011819D0 GB 201011819 A GB201011819 A GB 201011819A GB 201011819 D0 GB201011819 D0 GB 201011819D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- neurodegenerative disorders
- neurodegenerative
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1011819.8A GB201011819D0 (en) | 2010-07-14 | 2010-07-14 | Neurodegenerative disorders |
| GB1306866.3A GB2497502A (en) | 2010-07-14 | 2011-07-11 | Neurodegenerative Disorders |
| PCT/GB2011/051291 WO2012007740A1 (en) | 2010-07-14 | 2011-07-11 | Neurodegenerative disorders |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1011819.8A GB201011819D0 (en) | 2010-07-14 | 2010-07-14 | Neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201011819D0 true GB201011819D0 (en) | 2010-09-01 |
Family
ID=42734915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1011819.8A Ceased GB201011819D0 (en) | 2010-07-14 | 2010-07-14 | Neurodegenerative disorders |
| GB1306866.3A Withdrawn GB2497502A (en) | 2010-07-14 | 2011-07-11 | Neurodegenerative Disorders |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1306866.3A Withdrawn GB2497502A (en) | 2010-07-14 | 2011-07-11 | Neurodegenerative Disorders |
Country Status (2)
| Country | Link |
|---|---|
| GB (2) | GB201011819D0 (en) |
| WO (1) | WO2012007740A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106632664B (en) * | 2017-01-12 | 2020-07-10 | 沈阳药科大学 | Apolipoprotein II/I and preparation method, biological function and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7964598B2 (en) | 1995-10-17 | 2011-06-21 | The J. David Gladstone Institutes | ApoE4 domain interaction inhibitors and methods of use thereof |
| WO2003045321A2 (en) * | 2001-11-26 | 2003-06-05 | Exelixis, Inc. | MBMs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHODS OF USE |
| US20040101874A1 (en) * | 2002-04-12 | 2004-05-27 | Mitokor Inc. | Targets for therapeutic intervention identified in the mitochondrial proteome |
| WO2004038003A2 (en) * | 2002-10-25 | 2004-05-06 | Five Prime Therapeutics, Inc. | Human polypeptides encoded by polynucleotides and methods of their use |
| WO2008024114A1 (en) * | 2006-08-24 | 2008-02-28 | Genizon Biosciences Inc. | Genemap of the human genes associated with schizophrenia |
-
2010
- 2010-07-14 GB GBGB1011819.8A patent/GB201011819D0/en not_active Ceased
-
2011
- 2011-07-11 WO PCT/GB2011/051291 patent/WO2012007740A1/en not_active Ceased
- 2011-07-11 GB GB1306866.3A patent/GB2497502A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2497502A (en) | 2013-06-12 |
| GB201306866D0 (en) | 2013-05-29 |
| WO2012007740A1 (en) | 2012-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3607A (en) | Substituted imidazopyridazines | |
| TWI560388B (en) | Dampferzeugerheizrohrreparaturmittel und reparaturverfahren | |
| GB201206982D0 (en) | X-system | |
| PL2534132T3 (en) | Substituted pyrrolidine-2-carboxamides | |
| ZA201304139B (en) | Combination | |
| ZA201304430B (en) | Substituted sodium-1h-pyrazole-5-olate | |
| PL2606715T3 (en) | Baler-wrapper combination | |
| PL3901164T3 (en) | Gluten-related disorders | |
| EP2572199A4 (en) | Combination | |
| EP2571358A4 (en) | Combination | |
| GB2512771B (en) | Ablutionary fitting | |
| EP2588088A4 (en) | Solid forms | |
| GB201306866D0 (en) | Neurodegenerative Disorders | |
| SI2607602T1 (en) | Sunscreen | |
| EP2603078A4 (en) | Combination | |
| GB201113102D0 (en) | Zap it | |
| GB201117693D0 (en) | Combination | |
| GB201116007D0 (en) | Combination | |
| GB201106339D0 (en) | Combination | |
| GB201121105D0 (en) | Combination | |
| GB201101836D0 (en) | C It Now | |
| GB201020548D0 (en) | My clear step-plan | |
| GB201120794D0 (en) | Duo drinkster | |
| GB201000737D0 (en) | Dendrimers | |
| EP2654755A4 (en) | Combination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |